HEADER TRANSFERASE/TRANSFERASE INHIBITOR 23-SEP-11 3TXO TITLE PKC ETA KINASE IN COMPLEX WITH A NAPHTHYRIDINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN KINASE C ETA TYPE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 333-683; COMPND 5 SYNONYM: PKC-L, NPKC-ETA; COMPND 6 EC: 2.7.11.13; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PRKCH, PKCL, PRKCL; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE, PHOSPHOTRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR W.STARK,G.RUMMEL,S.W.COWAN-JACOB REVDAT 2 07-DEC-11 3TXO 1 JRNL REVDAT 1 30-NOV-11 3TXO 0 JRNL AUTH M.J.VAN EIS,J.P.EVENOU,P.FLOERSHEIM,C.GAUL,S.W.COWAN-JACOB, JRNL AUTH 2 L.MONOVICH,G.RUMMEL,W.SCHULER,W.STARK,A.STRAUSS,A.MATT, JRNL AUTH 3 E.VANGREVELINGHE,J.WAGNER,N.SOLDERMANN JRNL TITL 2,6-NAPHTHYRIDINES AS POTENT AND SELECTIVE INHIBITORS OF THE JRNL TITL 2 NOVEL PROTEIN KINASE C ISOZYMES. JRNL REF BIOORG.MED.CHEM.LETT. V. 21 7367 2011 JRNL REFN ISSN 0960-894X JRNL PMID 22078216 JRNL DOI 10.1016/J.BMCL.2011.10.025 REMARK 2 REMARK 2 RESOLUTION. 2.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 56.89 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 25157 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.196 REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1325 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.05 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.10 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1834 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.00 REMARK 3 BIN R VALUE (WORKING SET) : 0.2610 REMARK 3 BIN FREE R VALUE SET COUNT : 97 REMARK 3 BIN FREE R VALUE : 0.2830 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2594 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 22 REMARK 3 SOLVENT ATOMS : 139 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.37 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.79000 REMARK 3 B22 (A**2) : -0.44000 REMARK 3 B33 (A**2) : 1.23000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.166 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.117 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.274 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.955 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.933 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2684 ; 0.023 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3630 ; 1.982 ; 1.972 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 316 ; 6.556 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 137 ;38.954 ;24.088 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 461 ;17.061 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 17 ;17.611 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 382 ; 0.143 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2066 ; 0.010 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1586 ; 1.328 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2563 ; 2.336 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1098 ; 3.432 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1067 ; 5.388 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3TXO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-OCT-11. REMARK 100 THE RCSB ID CODE IS RCSB068049. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-NOV-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99180 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25157 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.050 REMARK 200 RESOLUTION RANGE LOW (A) : 63.370 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.09100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.05 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1 UL PROTEIN (18MG/ML IN 0.25 M NACL, REMARK 280 0.025 M TRIS PH 7.8, 4MM TCEP, 1MM EDTA) WITH 3-4 UL REMARK 280 CRYSTALLISATION BUFFER (25 % PEG3350 W/V, 200 MM CITRATE), FREE REMARK 280 INTERFACE DIFUSION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 56.76650 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.43050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 56.76650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 28.43050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: DIMER IN CRYSTAL DUE TO DOMAIN SWAPPING REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3180 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29920 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 56.86100 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 331 REMARK 465 PRO A 332 REMARK 465 LYS A 333 REMARK 465 GLU A 334 REMARK 465 SER A 335 REMARK 465 SER A 336 REMARK 465 LYS A 337 REMARK 465 GLU A 338 REMARK 465 GLY A 339 REMARK 465 ASN A 340 REMARK 465 GLY A 341 REMARK 465 ILE A 342 REMARK 465 GLY A 343 REMARK 465 VAL A 344 REMARK 465 ASN A 345 REMARK 465 SER A 346 REMARK 465 SER A 347 REMARK 465 ASN A 348 REMARK 465 ARG A 349 REMARK 465 LEU A 350 REMARK 465 GLY A 351 REMARK 465 ILE A 352 REMARK 465 ASN A 507 REMARK 465 GLY A 508 REMARK 465 VAL A 509 REMARK 465 THR A 510 REMARK 465 THR A 511 REMARK 465 ALA A 512 REMARK 465 THR A 513 REMARK 465 PHE A 514 REMARK 465 CYS A 515 REMARK 465 GLU A 680 REMARK 465 LEU A 681 REMARK 465 GLN A 682 REMARK 465 PRO A 683 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 12 O HOH A 125 2555 2.09 REMARK 500 O HOH A 157 O HOH A 157 2565 2.09 REMARK 500 O HOH A 156 O HOH A 156 2555 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 TYR A 545 CE2 TYR A 545 CD2 0.094 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 409 CA - CB - CG ANGL. DEV. = 18.9 DEGREES REMARK 500 GLU A 524 CA - CB - CG ANGL. DEV. = 15.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 354 65.18 -112.03 REMARK 500 PHE A 366 6.48 -64.11 REMARK 500 ARG A 449 -56.60 76.08 REMARK 500 ARG A 478 -16.47 71.88 REMARK 500 ASP A 497 93.31 77.42 REMARK 500 MET A 589 45.50 -87.26 REMARK 500 ASN A 673 32.37 -94.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 07U A 1 DBREF 3TXO A 333 683 UNP P24723 KPCL_HUMAN 333 683 SEQADV 3TXO GLY A 331 UNP P24723 EXPRESSION TAG SEQADV 3TXO PRO A 332 UNP P24723 EXPRESSION TAG SEQADV 3TXO GLU A 675 UNP P24723 SER 675 ENGINEERED MUTATION SEQRES 1 A 353 GLY PRO LYS GLU SER SER LYS GLU GLY ASN GLY ILE GLY SEQRES 2 A 353 VAL ASN SER SER ASN ARG LEU GLY ILE ASP ASN PHE GLU SEQRES 3 A 353 PHE ILE ARG VAL LEU GLY LYS GLY SER PHE GLY LYS VAL SEQRES 4 A 353 MET LEU ALA ARG VAL LYS GLU THR GLY ASP LEU TYR ALA SEQRES 5 A 353 VAL LYS VAL LEU LYS LYS ASP VAL ILE LEU GLN ASP ASP SEQRES 6 A 353 ASP VAL GLU CYS THR MET THR GLU LYS ARG ILE LEU SER SEQRES 7 A 353 LEU ALA ARG ASN HIS PRO PHE LEU THR GLN LEU PHE CYS SEQRES 8 A 353 CYS PHE GLN THR PRO ASP ARG LEU PHE PHE VAL MET GLU SEQRES 9 A 353 PHE VAL ASN GLY GLY ASP LEU MET PHE HIS ILE GLN LYS SEQRES 10 A 353 SER ARG ARG PHE ASP GLU ALA ARG ALA ARG PHE TYR ALA SEQRES 11 A 353 ALA GLU ILE ILE SER ALA LEU MET PHE LEU HIS ASP LYS SEQRES 12 A 353 GLY ILE ILE TYR ARG ASP LEU LYS LEU ASP ASN VAL LEU SEQRES 13 A 353 LEU ASP HIS GLU GLY HIS CYS LYS LEU ALA ASP PHE GLY SEQRES 14 A 353 MET CYS LYS GLU GLY ILE CYS ASN GLY VAL THR THR ALA SEQRES 15 A 353 THR PHE CYS GLY THR PRO ASP TYR ILE ALA PRO GLU ILE SEQRES 16 A 353 LEU GLN GLU MET LEU TYR GLY PRO ALA VAL ASP TRP TRP SEQRES 17 A 353 ALA MET GLY VAL LEU LEU TYR GLU MET LEU CYS GLY HIS SEQRES 18 A 353 ALA PRO PHE GLU ALA GLU ASN GLU ASP ASP LEU PHE GLU SEQRES 19 A 353 ALA ILE LEU ASN ASP GLU VAL VAL TYR PRO THR TRP LEU SEQRES 20 A 353 HIS GLU ASP ALA THR GLY ILE LEU LYS SER PHE MET THR SEQRES 21 A 353 LYS ASN PRO THR MET ARG LEU GLY SER LEU THR GLN GLY SEQRES 22 A 353 GLY GLU HIS ALA ILE LEU ARG HIS PRO PHE PHE LYS GLU SEQRES 23 A 353 ILE ASP TRP ALA GLN LEU ASN HIS ARG GLN ILE GLU PRO SEQRES 24 A 353 PRO PHE ARG PRO ARG ILE LYS SER ARG GLU ASP VAL SER SEQRES 25 A 353 ASN PHE ASP PRO ASP PHE ILE LYS GLU GLU PRO VAL LEU SEQRES 26 A 353 TPO PRO ILE ASP GLU GLY HIS LEU PRO MET ILE ASN GLN SEQRES 27 A 353 ASP GLU PHE ARG ASN PHE GLU TYR VAL SER PRO GLU LEU SEQRES 28 A 353 GLN PRO MODRES 3TXO TPO A 656 THR PHOSPHOTHREONINE HET TPO A 656 11 HET 07U A 1 22 HETNAM TPO PHOSPHOTHREONINE HETNAM 07U 2-METHYL-N~1~-[3-(PYRIDIN-4-YL)-2,6-NAPHTHYRIDIN-1- HETNAM 2 07U YL]PROPANE-1,2-DIAMINE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO C4 H10 N O6 P FORMUL 2 07U C17 H19 N5 FORMUL 3 HOH *139(H2 O) HELIX 1 1 LYS A 388 ASP A 395 1 8 HELIX 2 2 ASP A 396 ALA A 410 1 15 HELIX 3 3 ASP A 440 ARG A 449 1 10 HELIX 4 4 ASP A 452 LYS A 473 1 22 HELIX 5 5 LYS A 481 ASP A 483 5 3 HELIX 6 6 THR A 517 ILE A 521 5 5 HELIX 7 7 ALA A 522 TYR A 531 1 10 HELIX 8 8 PRO A 533 GLY A 550 1 18 HELIX 9 9 ASN A 558 ASP A 569 1 12 HELIX 10 10 HIS A 578 MET A 589 1 12 HELIX 11 11 ASN A 592 ARG A 596 5 5 HELIX 12 12 SER A 599 GLY A 604 5 6 HELIX 13 13 GLU A 605 ARG A 610 1 6 HELIX 14 14 HIS A 611 LYS A 615 5 5 HELIX 15 15 ASP A 618 HIS A 624 1 7 HELIX 16 16 ASP A 645 LYS A 650 1 6 HELIX 17 17 HIS A 662 ILE A 666 5 5 HELIX 18 18 ASN A 667 ARG A 672 5 6 SHEET 1 A 6 PHE A 355 GLY A 364 0 SHEET 2 A 6 GLY A 367 VAL A 374 -1 O VAL A 369 N LEU A 361 SHEET 3 A 6 LEU A 380 LYS A 387 -1 O VAL A 385 N LYS A 368 SHEET 4 A 6 ARG A 428 GLU A 434 -1 O MET A 433 N ALA A 382 SHEET 5 A 6 LEU A 419 GLN A 424 -1 N CYS A 421 O VAL A 432 SHEET 6 A 6 TYR A 676 VAL A 677 -1 O TYR A 676 N CYS A 422 SHEET 1 B 2 VAL A 485 LEU A 487 0 SHEET 2 B 2 CYS A 493 LEU A 495 -1 O LYS A 494 N LEU A 486 LINK C LEU A 655 N TPO A 656 1555 1555 1.33 LINK C TPO A 656 N PRO A 657 1555 1555 1.37 SITE 1 AC1 10 PHE A 366 VAL A 369 ALA A 382 LYS A 384 SITE 2 AC1 10 GLU A 434 VAL A 436 ASP A 440 ASP A 483 SITE 3 AC1 10 LEU A 486 ASP A 497 CRYST1 113.533 56.861 63.367 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008808 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017587 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015781 0.00000